Longitudinal spatial profiling reveals coordinated tumor signaling and immune remodeling during acquired resistance to darovasertib plus crizotinib in metastatic uveal melanoma (SITC 2026) - Oct 2, 2026 - Abstract #727; Pres time: Nov 6, 2026; 10:00 AM - 07:00 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available
Metastases • Preclinical • Tumor signal • Eye Cancer • Melanoma • Oncology • Solid Tumor • Uveal Melanoma
|